Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meeting

Documenti analoghi

• Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice
  di: Clifford R. Jack, et al.
  Pubblicazione: (2024)
• Biomarkers in Alzheimer's disease clinical trials: 2025
  di: Amanda M. Leisgang Osse, et al.
  Pubblicazione: (2026)
• Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
  di: Ronald C. Petersen, et al.
  Pubblicazione: (2025)
• Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
  di: Jeffrey Cummings
  Pubblicazione: (2025)
• The PSYCHS instrument to assess criteria for clinical high risk of psychosis
  di: Merete Nordentoft
  Pubblicazione: (2024)